Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 3
1988 2
1989 2
1990 1
2010 1
2011 2
2012 7
2013 7
2014 3
2015 4
2016 2
2018 1
2019 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

31 results
Results by year
Filters applied: . Clear all
Page 1
Cabazitaxel: a novel microtubule inhibitor.
Villanueva C, Bazan F, Kim S, Demarchi M, Chaigneau L, Thiery-Vuillemin A, Nguyen T, Cals L, Dobi E, Pivot X. Villanueva C, et al. Among authors: dobi e. Drugs. 2011 Jul 9;71(10):1251-8. doi: 10.2165/11591390-000000000-00000. Drugs. 2011. PMID: 21770474 Review.
[KIT and KIT: from biology to clinical use].
Curtit E, Mansi L, Viel E, Dobi E, Chaigneau L, Nguyen T, Pivot X, Blay JY, Kalbacher E. Curtit E, et al. Among authors: dobi e. Bull Cancer. 2012 Feb 1;99(2):191-7. doi: 10.1684/bdc.2011.1386. Bull Cancer. 2012. PMID: 21669561 Free article. French.
[Prevalence and management of pain in patients with metastatic cancer in Franche-Comté].
Dénommé F, Kroemer M, Montcuquet P, Nallet G, Thiery-Vuillemin A, Bazan F, Mouillet G, Villanueva C, Demarchi M, Stein U, Almotlak H, Chaigneau L, Curtit E, Meneveau N, Maurina T, Dobi E, Hon TN, Cals L, Mansi L, Verlut C, Pana-Katatali H, Caubet M, Paillard MJ, Limat S, Pivot X, Nerich V. Dénommé F, et al. Among authors: dobi e. Bull Cancer. 2016 Oct;103(10):849-860. doi: 10.1016/j.bulcan.2016.08.007. Epub 2016 Sep 29. Bull Cancer. 2016. PMID: 27692731 French.
[Efficacy, safety and cost of eribulin in patients with metastatic breast cancer].
Paillard MJ, Curtit E, Dobi E, Mansi L, Bazan F, Villanueva C, Chaigneau L, Montcuquet P, Meneveau N, Thiery-Vuillemin A, Nerich V, Pivot X. Paillard MJ, et al. Among authors: dobi e. Bull Cancer. 2015 Sep;102(9):737-48. doi: 10.1016/j.bulcan.2015.03.021. Epub 2015 May 26. Bull Cancer. 2015. PMID: 26022285 French.
In the era of genomics, should tumor size be reconsidered as a criterion for neoadjuvant chemotherapy?
Pivot X, Mansi L, Chaigneau L, Montcuquet P, Thiery-Vuillemin A, Bazan F, Dobi E, Sautiere JL, Rigenbach F, Algros MP, Butler S, Jamshidian F, Febbo P, Svedman C, Paget-Bailly S, Bonnetain F, Villanueva C. Pivot X, et al. Among authors: dobi e. Oncologist. 2015 Apr;20(4):344-50. doi: 10.1634/theoncologist.2014-0198. Epub 2015 Mar 20. Oncologist. 2015. PMID: 25795632 Free PMC article. Clinical Trial.
Specific anticancer treatments in the last 3 months of life: a French experience.
Viel E, Chaigneau L, Fanton E, Kalbacher E, Thiery-Vuillemnin A, Villanueva C, Dobi E, Curtit E, Almotlak H, Aubry R, Pivot X. Viel E, et al. Among authors: dobi e. Support Care Cancer. 2013 Feb;21(2):405-12. doi: 10.1007/s00520-012-1529-1. Epub 2012 Jun 27. Support Care Cancer. 2013. PMID: 22736464
31 results